Atoncy (atomoxetine hydrochloride)

New dosage form

Region: 🇺🇸 US
Active substance: atomoxetine hydrochloride
Company: Map77
Status: Approved
FDA approval: Fri 20 Mar 2026
Designations: New dosage form
Application: NDA220320
Official record: www.accessdata.fda.gov

Regulatory milestones

Fri 20 Mar 2026🇺🇸 FDA approval

FDA approves Atoncy (atomoxetine hydrochloride): new dosage form

Map77; NDA220320; New dosage form; solution · source

Follow Atoncy

Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.